David N. Schwartz

2.1k total citations
56 papers, 1.4k citations indexed

About

David N. Schwartz is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Infectious Diseases. According to data from OpenAlex, David N. Schwartz has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 17 papers in Applied Microbiology and Biotechnology and 11 papers in Infectious Diseases. Recurrent topics in David N. Schwartz's work include Antibiotic Use and Resistance (17 papers), Patient Satisfaction in Healthcare (8 papers) and Pneumonia and Respiratory Infections (8 papers). David N. Schwartz is often cited by papers focused on Antibiotic Use and Resistance (17 papers), Patient Satisfaction in Healthcare (8 papers) and Pneumonia and Respiratory Infections (8 papers). David N. Schwartz collaborates with scholars based in United States, Israel and Canada. David N. Schwartz's co-authors include Robert A. Weinstein, Andrew J. Pierre, Rajender Agarwal, Arthur T. Evans, Mary F. Wisniewski, C. William Wester, Shahid Husain, Lakshmi Durairaj, Gail S. Itokazu and Paul R. Yarnold and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Microbiology Reviews and Clinical Infectious Diseases.

In The Last Decade

David N. Schwartz

53 papers receiving 1.3k citations

Peers

David N. Schwartz
Valerie M. Vaughn United States
William Farrer United States
Philip Howard United Kingdom
Edward Stenehjem United States
Sarah K. Parker United States
Daniel J. Shapiro United States
Payal Patel United States
Valerie M. Vaughn United States
David N. Schwartz
Citations per year, relative to David N. Schwartz David N. Schwartz (= 1×) peers Valerie M. Vaughn

Countries citing papers authored by David N. Schwartz

Since Specialization
Citations

This map shows the geographic impact of David N. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Schwartz more than expected).

Fields of papers citing papers by David N. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Schwartz. The network helps show where David N. Schwartz may publish in the future.

Co-authorship network of co-authors of David N. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Schwartz. A scholar is included among the top collaborators of David N. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Schwartz. David N. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwartz, David N., et al.. (2024). Jmvx: Fast Multi-threaded Multi-version Execution and Record-Replay for Managed Languages. Proceedings of the ACM on Programming Languages. 8(OOPSLA2). 1641–1669. 1 indexed citations
2.
Schwartz, David N., et al.. (2023). Cultures of antibiotic prescribing in medical intensive care. Social Science & Medicine. 324. 115834–115834. 7 indexed citations
3.
Schwartz, David N., et al.. (2019). Antibiotic decision making in surgical intensive care: a qualitative analysis. Journal of Hospital Infection. 104(2). 158–164. 5 indexed citations
4.
Hamilton, Keith, Jeffrey S. Gerber, Rebekah W. Moehring, et al.. (2015). Point-of-Prescription Interventions to Improve Antimicrobial Stewardship. Clinical Infectious Diseases. 60(8). 1252–1258. 26 indexed citations
5.
Danziger, Larry H., et al.. (2013). How low can you go? Use of low- and standard-dose liposomal amphotericin B for treatment of invasive fungal infections. International Journal of Infectious Diseases. 17(8). e615–e620. 6 indexed citations
6.
Agarwal, Rajender & David N. Schwartz. (2011). Procalcitonin to Guide Duration of Antimicrobial Therapy in Intensive Care Units: A Systematic Review. Clinical Infectious Diseases. 53(4). 379–387. 81 indexed citations
7.
Schwartz, David N., R. Scott Evans, Bernard Camins, et al.. (2011). Deriving Measures of Intensive Care Unit Antimicrobial Use from Computerized Pharmacy Data: Methods, Validation, and Overcoming Barriers. Infection Control and Hospital Epidemiology. 32(5). 472–480. 20 indexed citations
8.
Leventhal, Douglas D. & David N. Schwartz. (2008). Infratemporal Fossa Abscess. Archives of Otolaryngology - Head and Neck Surgery. 134(5). 551–551. 14 indexed citations
9.
Weisman, Steven M. & David N. Schwartz. (2007). Studying women in clinical trials: Scientific and legal implications. Gender Medicine. 4(1). 3–7. 1 indexed citations
10.
Madariaga, Miguel G., Arthur T. Evans, Martin Phillips, et al.. (2006). Learning by doing: developing fellows’ academic skills through collaborative research. Medical Teacher. 28(1). 77–80. 14 indexed citations
11.
Parada, Jorge P., David N. Schwartz, Gordon D. Schiff, & Kevin B. Weiss. (2005). Effects of type and level of training on variation in physician knowledge in the use and acquisition of blood cultures: a cross sectional survey. BMC Infectious Diseases. 5(1). 71–71. 8 indexed citations
12.
Rezai, Katayoun, Arthur T. Evans, Miguel G. Madariaga, et al.. (2004). Why Don't They Listen? Adherence to Recommendations of Infectious Disease Consultations. Clinical Infectious Diseases. 38(9). 1212–1218. 46 indexed citations
13.
Zagorski, Brandon, William E. Trick, David N. Schwartz, et al.. (2002). The Effect of Renal Dysfunction on Antimicrobial Use Measurements. Clinical Infectious Diseases. 35(12). 1491–1497. 34 indexed citations
14.
Wester, C. William, et al.. (2002). Antibiotic Resistance. Archives of Internal Medicine. 162(19). 2210–2210. 137 indexed citations
15.
Arozullah, Ahsan M., Paul R. Yarnold, Robert A. Weinstein, et al.. (2000). A New Preadmission Staging System for Predicting Inpatient Mortality from HIV-associated Pneumocystis carinii Pneumonia in the Early Highly Active Antiretroviral Therapy (HAART) Era. American Journal of Respiratory and Critical Care Medicine. 161(4). 1081–1086. 39 indexed citations
16.
Curtis, J. Randall, Paul R. Yarnold, David N. Schwartz, Robert A. Weinstein, & Charles L. Bennett. (2000). Improvements in Outcomes of Acute Respiratory Failure for Patients with Human Immunodeficiency Virus-related Pneumocystis carinii Pneumonia. American Journal of Respiratory and Critical Care Medicine. 162(2). 393–398. 70 indexed citations
17.
Bennett, Charles L., David N. Schwartz, Jorge P. Parada, et al.. (2000). Delays in Tuberculosis Isolation and Suspicion Among Persons Hospitalized With HIV-Related Pneumonia. CHEST Journal. 117(1). 110–116. 23 indexed citations
18.
Schwartz, David N., Barbara Schable, Fred C. Tenover, & Richard A. Miller. (1995). Leptotrichia buccalis Bacteremia in Patients Treated in a Single Bone Marrow Transplant Unit. Clinical Infectious Diseases. 20(4). 762–767. 24 indexed citations
19.
Schwartz, David N., Stephan D. Fihn, & Richard Miller. (1993). Infection of an Arterial Prosthesis as the Presenting Manifestation of Disseminated Coccidioidomycosis: Control of Disease with Fluconazole. Clinical Infectious Diseases. 16(4). 486–488. 5 indexed citations
20.
Schwartz, David N., et al.. (1987). Improvement of olfaction in laeyngectomized patients with the larynx bypass. The Laryngoscope. 97(11). 1280–1286. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026